• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Cautious Optimism Warranted for Stem Cell-Derived Islet Transplantation in Type 2 Diabetes.

作者信息

Scholz Hanne, Sordi Valeria, Piemonti Lorenzo

机构信息

Department of Transplant Medicine and Institute for Surgical Research, Oslo University Hospital, Oslo, Norway.

Hybrid Technology Hub Centre of Excellence, Institute of Basic Medical Science, University of Oslo, Oslo, Norway.

出版信息

Transpl Int. 2024 Jul 26;37:13358. doi: 10.3389/ti.2024.13358. eCollection 2024.

DOI:10.3389/ti.2024.13358
PMID:39131791
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11310020/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0178/11310020/a0bfae3e8b33/ti-37-13358-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0178/11310020/a0bfae3e8b33/ti-37-13358-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0178/11310020/a0bfae3e8b33/ti-37-13358-g001.jpg

相似文献

1
Cautious Optimism Warranted for Stem Cell-Derived Islet Transplantation in Type 2 Diabetes.对2型糖尿病中干细胞衍生胰岛移植持谨慎乐观态度是有道理的。
Transpl Int. 2024 Jul 26;37:13358. doi: 10.3389/ti.2024.13358. eCollection 2024.
2
Advances in Cell Replacement Therapies for Diabetes.糖尿病细胞替代疗法的进展
Diabetes. 2025 Apr 24. doi: 10.2337/db25-0037.
3
Advancements in transplantation therapy for diabetes: Pancreas, islet and stem cell.糖尿病移植治疗的进展：胰腺、胰岛和干细胞。
J Diabetes Investig. 2021 Feb;12(2):143-145. doi: 10.1111/jdi.13358. Epub 2020 Aug 27.
4
Human Induced Pluripotent Stem Cells in the Curative Treatment of Diabetes and Potential Impediments Ahead.人类诱导多能干细胞在糖尿病治疗中的应用及潜在障碍
Adv Exp Med Biol. 2019;1144:25-35. doi: 10.1007/5584_2018_305.
5
Tumor-Free Transplantation of Patient-Derived Induced Pluripotent Stem Cell Progeny for Customized Islet Regeneration.用于定制化胰岛再生的患者来源诱导多能干细胞后代的无瘤移植
Stem Cells Transl Med. 2016 May;5(5):694-702. doi: 10.5966/sctm.2015-0017. Epub 2016 Mar 17.
6
Embryonic stem cells and islet replacement in diabetes mellitus.胚胎干细胞与糖尿病中的胰岛替代
Pediatr Diabetes. 2004;5 Suppl 2:5-15. doi: 10.1111/j.1399-543X.2004.00074.x.
7
Islet organoids: a new hope for islet transplantation in diabetes.胰岛类器官：糖尿病胰岛移植的新希望。
Front Immunol. 2025 Jan 21;15:1540209. doi: 10.3389/fimmu.2024.1540209. eCollection 2024.
8
Microchip-based engineering of super-pancreatic islets supported by adipose-derived stem cells.基于微芯片的工程化胰岛样细胞簇，由脂肪来源的干细胞支持。
Biomaterials. 2014 Jun;35(17):4815-26. doi: 10.1016/j.biomaterials.2014.02.045. Epub 2014 Mar 15.
9
[Research progress on the donor cell sources of pancreatic islet transplantation for treatment of diabetes mellitus].[用于治疗糖尿病的胰岛移植供体细胞来源的研究进展]
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2018 Jan 15;32(1):104-111. doi: 10.7507/1002-1892.201707049.
10
Ameliorating and refining islet organoids to illuminate treatment and pathogenesis of diabetes mellitus.改善和优化胰岛类器官以阐明糖尿病的治疗和发病机制。
Stem Cell Res Ther. 2024 Jun 27;15(1):188. doi: 10.1186/s13287-024-03780-7.

引用本文的文献

1
Allogeneic Islet Transplantation: Chronicle of a Death Foretold?同种异体胰岛移植：一场预先注定的死亡纪事？
Transpl Int. 2025 Apr 1;38:14598. doi: 10.3389/ti.2025.14598. eCollection 2025.

本文引用的文献

1
Two-year safety outcomes of iPS cell-derived mesenchymal stromal cells in acute steroid-resistant graft-versus-host disease.iPS 细胞来源的间充质基质细胞治疗急性激素耐药移植物抗宿主病的 2 年安全性结果。
Nat Med. 2024 Jun;30(6):1556-1558. doi: 10.1038/s41591-024-02990-z. Epub 2024 May 22.
2
Treating a type 2 diabetic patient with impaired pancreatic islet function by personalized endoderm stem cell-derived islet tissue.用个性化的内胚层干细胞衍生的胰岛组织治疗胰岛功能受损的2型糖尿病患者。
Cell Discov. 2024 Apr 30;10(1):45. doi: 10.1038/s41421-024-00662-3.
3
Illuminating the complete ß-cell mass of the human pancreas- signifying a new view on the islets of Langerhans.
阐明人类胰腺中的完整β细胞群——标志着对胰岛的新认识。
Nat Commun. 2024 Apr 18;15(1):3318. doi: 10.1038/s41467-024-47686-7.
4
Good Manufacturing Practice-compliant human induced pluripotent stem cells: from bench to putative clinical products.符合良好生产规范的人诱导多能干细胞：从实验室到潜在的临床产品。
Cytotherapy. 2024 Jun;26(6):556-566. doi: 10.1016/j.jcyt.2024.02.021. Epub 2024 Mar 5.
5
6. Glycemic Goals and Hypoglycemia: Standards of Care in Diabetes-2024.6. 血糖目标与低血糖：2024年糖尿病诊疗标准
Diabetes Care. 2024 Jan 1;47(Suppl 1):S111-S125. doi: 10.2337/dc24-S006.
6
Early time-restricted carbohydrate consumption vs conventional dieting in type 2 diabetes: a randomised controlled trial.限时碳水化合物摄入与 2 型糖尿病常规饮食疗法的随机对照试验。
Diabetologia. 2024 Feb;67(2):263-274. doi: 10.1007/s00125-023-06045-9. Epub 2023 Nov 16.
7
The Relevance of Advanced Therapy Medicinal Products in the Field of Transplantation and the Need for Academic Research Access: Overcoming Bottlenecks and Claiming a New Time.先进治疗药品在移植领域的相关性及学术研究获取的必要性：克服瓶颈，开创崭新时代
Transpl Int. 2023 Sep 27;36:11633. doi: 10.3389/ti.2023.11633. eCollection 2023.
8
Association between primary graft function and 5-year outcomes of islet allogeneic transplantation in type 1 diabetes: a retrospective, multicentre, observational cohort study in 1210 patients from the Collaborative Islet Transplant Registry.胰岛同种异体移植治疗 1 型糖尿病患者的原发性移植物功能与 5 年结局的相关性：来自协作胰岛移植登记处的 1210 例患者的回顾性、多中心观察性队列研究。
Lancet Diabetes Endocrinol. 2023 Jun;11(6):391-401. doi: 10.1016/S2213-8587(23)00082-7. Epub 2023 Apr 24.
9
Stepwise differentiation of functional pancreatic β cells from human pluripotent stem cells.从人多能干细胞逐步分化出功能性胰腺β细胞。
Cell Regen. 2022 Aug 1;11(1):24. doi: 10.1186/s13619-022-00125-8.
10
A phase 1b randomised controlled trial of a glucagon-like peptide-1 and glucagon receptor dual agonist IBI362 (LY3305677) in Chinese patients with type 2 diabetes.一项在中国 2 型糖尿病患者中进行的胰高血糖素样肽-1 和胰高血糖素受体双重激动剂 IBI362（LY3305677）的 1b 期随机对照试验。
Nat Commun. 2022 Jun 24;13(1):3613. doi: 10.1038/s41467-022-31328-x.